OptimizeRx Corporation (OPRX)

OptimizeRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.59	13.38	13.85	18.21	84.68	10.52
Short-Term Investments	-	-	-	55.93	-	-
Cash & Short-Term Investments	16.59	13.38	13.85	74.14	84.68	10.52
Cash Growth	10.87%	-3.41%	-81.32%	-12.45%	705.21%	-44.22%
Accounts Receivable	33.51	38.21	36.25	22.16	24.8	17.89
Other Receivables	0.65	-	1.04	-	-	-
Receivables	34.16	38.21	37.29	22.16	24.8	17.89
Prepaid Expenses	3.34	0.77	1.29	0.85	0.93	4.46
Other Current Assets	-	1.61	1.9	1.43	4.7	-
Total Current Assets	54.08	53.97	54.33	98.58	115.11	32.86
Property, Plant & Equipment	0.66	0.52	0.72	0.37	0.47	0.59
Goodwill	70.87	70.87	78.36	22.67	14.74	14.74
Other Intangible Assets	43.49	45.52	49.4	13.02	10.65	12.12
Other Long-Term Assets	0.16	0.3	0.57	0.01	0.01	0.01
Total Assets	169.27	171.17	183.37	134.65	140.99	60.33
Accounts Payable	1.98	2.16	2.23	1.55	0.61	0.62
Accrued Expenses	12.49	8.49	7.71	2.6	2.9	2.42
Current Portion of Long-Term Debt	3.3	2	2	-	-	-
Current Portion of Leases	0.21	0.17	0.22	0.09	0.09	0.12
Current Income Taxes Payable	-	0.32	0.05	-	-	-
Current Unearned Revenue	0.48	0.47	0.17	0.16	1.39	0.29
Other Current Liabilities	2.59	5.05	5.51	3.99	4.38	6.58
Total Current Liabilities	21.06	18.65	17.88	8.4	9.37	10.03
Long-Term Debt	25.13	30.82	34.23	-	-	-
Long-Term Leases	0.34	0.21	0.37	0.14	0.24	0.33
Long-Term Deferred Tax Liabilities	3.46	4.49	4.34	-	-	-
Total Liabilities	49.98	54.17	56.82	8.54	9.61	10.35
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	204.3	201.35	190.79	172.79	166.62	85.59
Retained Earnings	-85.04	-84.37	-64.26	-46.69	-35.25	-35.63
Treasury Stock	-0	-0	-0	-0	-	-
Shareholders' Equity	119.28	117	126.55	126.11	131.38	49.97
Total Liabilities & Equity	169.27	171.17	183.37	134.65	140.99	60.33
Total Debt	28.98	33.19	36.82	0.23	0.33	0.45
Net Cash (Debt)	-12.39	-19.81	-22.97	73.91	84.35	10.07
Net Cash Growth	-	-	-	-12.39%	737.84%	-44.95%
Net Cash Per Share	-0.67	-1.08	-1.34	4.16	4.77	0.68
Filing Date Shares Outstanding	18.57	18.49	18.18	17.1	17.88	16.81
Total Common Shares Outstanding	18.56	18.45	18.16	17.07	17.86	15.22
Working Capital	33.02	35.32	36.45	90.18	105.74	22.83
Book Value Per Share	6.43	6.34	6.97	7.39	7.36	3.28
Tangible Book Value	4.92	0.61	-1.2	90.41	105.99	23.11
Tangible Book Value Per Share	0.27	0.03	-0.07	5.30	5.93	1.52
Machinery	-	0.41	0.3	0.27	0.47	0.37

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q